BSX · Earnings call · 2026Q3T · Full report

Liquidity and Capital Position

BOSTON SCIENTIFIC CORP · 2026-10-28 · Importance 15 · Surprise 6

As of September 30, 2026, Boston Scientific had $690 million of cash on hand and a gross debt leverage ratio of 1.9x. Management described its capital allocation priorities as strategic tuck-in M&A and opportunistic share repurchases, while continuing to fund opportunities it believes will create long-term shareholder value.

Key facts

• As of September 30, 2026, Boston Scientific had $690 million cash on hand and a gross debt leverage ratio of 1.9x.